Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: A prospective randomized double-blind trial.

International journal of oncology

Volumn 16, Issue 4, 2000, Pages 815-824

  von Tempelhoff, G F ^a   Harenberg, J ^a   Niemann, F ^a   Hommel, G ^a   Kirkpatrick, C J ^a   Heilmann, L ^a  

^a Gesundheits und Pflegezentrum Russelsheim   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERTOPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; UTERINE CERVIX TUMOR;

ADULT; AGED; BREAST NEOPLASMS; DOUBLE-BLIND METHOD; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0034164514     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.16.4.815     Document Type: Article

References (0)